Rotavirus Gastroenteritis Clinical Trial
Official title:
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
Universal rotavirus vaccination program for infants born in Brest after February 2007,
applied by the Centers for Maternal and Infant Health Protection, pediatricians and general
practitioners.
Prospective surveillance of hospitalizations for gastroenteritis within the Pediatric Units
of Brest University Hospital with systematic testing for Rotavirus.
Evaluation of the impact of the vaccination program on rotaviral gastroenteritis
hospitalizations from 2007-2008 and 2008-2009, by comparison with epidemiological data from
2002-2007 in the absence of vaccination.
The principal judgement criterion is the number of pediatric hospitalizations for rotaviral
GEA during the 2008-2009 epidemic in children A) under the age of 2 and B) residing in the
suburbs of Brest.
n/a
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01575197 -
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
|
Phase 4 | |
| Completed |
NCT01202201 -
A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan
|
N/A | |
| Completed |
NCT00953056 -
A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)
|
Phase 1 | |
| Completed |
NCT00737503 -
Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab
|
Phase 4 | |
| Completed |
NCT04185545 -
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
|
Phase 3 | |
| Completed |
NCT03474055 -
Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India
|
Phase 2/Phase 3 | |
| Completed |
NCT01236066 -
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
|
N/A | |
| Completed |
NCT00489567 -
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
|
N/A | |
| Completed |
NCT02584816 -
Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization
|
Phase 3 | |
| Completed |
NCT02062385 -
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
|
Phase 3 | |
| Completed |
NCT02133690 -
A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
|
Phase 3 | |
| Completed |
NCT01177657 -
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
|
N/A | |
| Completed |
NCT01265355 -
Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement
|
Phase 2/Phase 3 | |
| Completed |
NCT00169455 -
Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants
|
Phase 3 | |
| Completed |
NCT04819412 -
To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus
|
Phase 3 | |
| Completed |
NCT02728869 -
Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05958771 -
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
|
Phase 3 | |
| Recruiting |
NCT01061658 -
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
|
Phase 1/Phase 2 | |
| Completed |
NCT01026779 -
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
|
||
| Completed |
NCT01508533 -
Epidemiology of Rotavirus Infection in North India Community
|
N/A |